2VSA.F
Price:
$4.836
Market Cap:
$417.96M
Verastem, Inc. is a biopharmaceutical firm in its development phase, concentrating on the advancement and market introduction of therapeutic agents for oncological conditions. A primary investigational compound is VS-6766 (also known as avutometinib). This agent functions as a RAF/MEK clamp, impeding MEK kinase activity and the capacity of RAF to phosphorylate MEK. Its pipeline includes RAMP 201, an adaptive, two-part, multicenter, parallel cohort, randomized, open-label clinical trial. This study assesses the effectiveness and safety of avutometinib, both as a standalone treatment and in conjunction with defactinib, an oral small molecule inhibitor of focal adhesion kinase (FAK), for indivi...[Read more]
Industry
Biotechnology
IPO Date
2012-02-13
Stock Exchange
FSX
Ticker
2VSA.F
According to Verastem, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 337.89M. This represents a change of -23.19% compared to the average of 439.88M of the last 4 quarters.
The mean historical Enterprise Value of Verastem, Inc. over the last ten years is 178.57M. The current 337.89M Enterprise Value has changed 18.82% with respect to the historical average. Over the past ten years (40 quarters), 2VSA.F's Enterprise Value was at its highest in in the June 2021 quarter at 698.56M. The Enterprise Value was at its lowest in in the June 2023 quarter at -8664920.00.
Average
178.57M
Median
153.56M
Minimum
9.08M
Maximum
406.94M
Discovering the peaks and valleys of Verastem, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 457.50%
Maximum Annual Enterprise Value = 406.94M
Minimum Annual Increase = -91.28%
Minimum Annual Enterprise Value = 9.08M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 406.94M | 194.73% |
| 2024 | 138.07M | -3.56% |
| 2023 | 143.17M | 383.77% |
| 2022 | 29.59M | -91.28% |
| 2021 | 339.46M | 20.65% |
| 2020 | 281.35M | 71.61% |
| 2019 | 163.95M | -26.64% |
| 2018 | 223.50M | 341.64% |
| 2017 | 50.61M | 457.50% |
| 2016 | 9.08M | -78.37% |
The current Enterprise Value of Verastem, Inc. (2VSA.F) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
229.39M
5-year avg
211.45M
10-year avg
178.57M
Verastem, Inc.’s Enterprise Value is greater than Formycon AG (253.53M), greater than Zura Bio Limited (128.78M), greater than Heidelberg Pharma AG (90.20M), greater than 4basebio PLC (80.00M), less than Medios AG (426.11M), greater than Stratec SE (330.76M), greater than BRAIN Biotech AG (60.85M), greater than Newron Pharmaceuticals S.p.A. (286.75M), greater than M1 Kliniken AG (317.26M), less than CureVac N.V. (536.23M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 253.53M | $312.81M | |
| 128.78M | $290.00M | |
| 90.20M | $115.09M | |
| 80.00M | $91.36M | |
| 426.11M | $316.27M | |
| 330.76M | $237.53M | |
| 60.85M | $60.30M | |
| 286.75M | $264.23M | |
| 317.26M | $344.77M | |
| 536.23M | $879.52M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Verastem, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Verastem, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Verastem, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Verastem, Inc. (2VSA.F)?
What is the 3-year average Enterprise Value for Verastem, Inc. (2VSA.F)?
What is the 5-year average Enterprise Value for Verastem, Inc. (2VSA.F)?
How does the current Enterprise Value for Verastem, Inc. (2VSA.F) compare to its historical average?